Literature DB >> 15385472

Escherichia coli cytotoxic necrotizing factor 1 inhibits intestinal epithelial wound healing in vitro after mechanical injury.

Patrick Brest1, Laurent Turchi, Gaëlle Le'Negrate, Frédérick Berto, Chimène Moreilhon, Bernard Mari, Gilles Ponzio, Paul Hofman.   

Abstract

Cytotoxic necrotizing factor type 1 (CNF1) from Escherichia coli activates the small GTP-binding proteins of the Rho family (Rho, Rac, and Cdc42) by catalyzing their deamidation at a specific glutamine residue. Since RhoA, Rac, and Cdc42 play a pivotal role in cell migration during the early phase of wound repair, we investigated whether CNF1 was able to interfere with wound healing in intestinal epithelial monolayers (T84 cells). After mechanical injury, we found that CNF1 blocks epithelial wound repair within 48 h. This effect was characterized by cell elongation and filopodium formation on the leading edge, in association with permanent phosphorylation of the focal adhesion kinase (FAK) via Rho activation. Moreover, inhibition of Rho kinase with Y-27632 decreased CNF1-mediated permanent FAK phosphorylation, leading to complete restitution of wound repair within 24 h. In addition, we found that CNF1 induced upregulation of mitogen-activated protein kinases (MAPK) activation. Moreover, activation of Rac and MAPK by CNF1 increased matrix metalloproteinase 9 expression in wounded T84 monolayers. Taken together, these results provide evidence that CNF1 strongly impairs intestinal epithelial wound healing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15385472      PMCID: PMC517525          DOI: 10.1128/IAI.72.10.5733-5740.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

Review 1.  Matrix metalloproteinases in repair.

Authors:  W C Parks
Journal:  Wound Repair Regen       Date:  1999 Nov-Dec       Impact factor: 3.617

Review 2.  Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells.

Authors:  K Kaibuchi; S Kuroda; M Amano
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

3.  Cytotoxic necrotizing factor type 1 of uropathogenic Escherichia coli kills cultured human uroepithelial 5637 cells by an apoptotic mechanism.

Authors:  M Mills; K C Meysick; A D O'Brien
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung.

Authors:  D C Underwood; R R Osborn; S Bochnowicz; E F Webb; D J Rieman; J C Lee; A M Romanic; J L Adams; D W Hay; D E Griswold
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-11       Impact factor: 5.464

5.  Signaling pathways and cell mechanics involved in wound closure by epithelial cell sheets.

Authors:  G Fenteany; P A Janmey; T P Stossel
Journal:  Curr Biol       Date:  2000-07-13       Impact factor: 10.834

Review 6.  Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement.

Authors:  J T Parsons; K H Martin; J K Slack; J M Taylor; S A Weed
Journal:  Oncogene       Date:  2000-11-20       Impact factor: 9.867

7.  Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways.

Authors:  W Eberhardt; A Huwiler; K F Beck; S Walpen; J Pfeilschifter
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

Review 8.  Rho GTPases: signaling, migration, and invasion.

Authors:  A A Schmitz; E E Govek; B Böttner; L Van Aelst
Journal:  Exp Cell Res       Date:  2000-11-25       Impact factor: 3.905

9.  Escherichia coli cytotoxic necrotizing factor-1 (CNF-1) increases the adherence to epithelia and the oxidative burst of human polymorphonuclear leukocytes but decreases bacteria phagocytosis.

Authors:  P Hofman; G Le Negrate; B Mograbi; V Hofman; P Brest; A Alliana-Schmid; G Flatau; P Boquet; B Rossi
Journal:  J Leukoc Biol       Date:  2000-10       Impact factor: 4.962

10.  Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice.

Authors:  D Ilić; Y Furuta; S Kanazawa; N Takeda; K Sobue; N Nakatsuji; S Nomura; J Fujimoto; M Okada; T Yamamoto
Journal:  Nature       Date:  1995-10-12       Impact factor: 49.962

View more
  5 in total

1.  Escherichia coli interaction with human brain microvascular endothelial cells induces signal transducer and activator of transcription 3 association with the C-terminal domain of Ec-gp96, the outer membrane protein A receptor for invasion.

Authors:  Ravi Maruvada; Yair Argon; Nemani V Prasadarao
Journal:  Cell Microbiol       Date:  2008-08-15       Impact factor: 3.715

2.  Virulence potential of Escherichia coli isolates from skin and soft tissue infections.

Authors:  Ziva Petkovsek; Kristina Elersic; Marija Gubina; Darja Zgur-Bertok; Marjanca Starcic Erjavec
Journal:  J Clin Microbiol       Date:  2009-04-08       Impact factor: 5.948

Review 3.  Effects of the Escherichia coli Bacterial Toxin Cytotoxic Necrotizing Factor 1 on Different Human and Animal Cells: A Systematic Review.

Authors:  Francesca Carlini; Zaira Maroccia; Carla Fiorentini; Sara Travaglione; Alessia Fabbri
Journal:  Int J Mol Sci       Date:  2021-11-22       Impact factor: 5.923

4.  Infection of (Peri-)Pancreatic Necrosis Is Associated with Increased Rates of Adverse Events during Endoscopic Drainage: A Retrospective Study.

Authors:  Fabian Frost; Laura Schlesinger; Mats L Wiese; Steffi Urban; Sabrina von Rheinbaben; Quang Trung Tran; Christoph Budde; Markus M Lerch; Tilman Pickartz; Ali A Aghdassi
Journal:  J Clin Med       Date:  2022-10-02       Impact factor: 4.964

5.  Campylobacter jejuni Triggers Signaling through Host Cell Focal Adhesions To Inhibit Cell Motility.

Authors:  Courtney M Klappenbach; Nicholas M Negretti; Jesse Aaron; Teng-Leong Chew; Michael E Konkel
Journal:  mBio       Date:  2021-08-24       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.